Literature DB >> 7281001

Combined Collis gastroplasty--fundoplication operations for scleroderma reflux esophagitis.

M B Orringer, J S Orringer, L Dabich, C J Zarafonetis.   

Abstract

Thirty-seven patients with scleroderma and reflux esophagitis, including 16 (43%) with peptic esophageal strictures, have been treated with a combination of the Collis gastroplasty and either a Belsey (240 degree) or Nissen (360 degree) fundoplication. Follow-up data have been obtained through personal interviews, esophageal manometry, and acid reflux testing. There have been no postoperative deaths or wound-healing complications. Five (31%) of the 16 patients with strictures still require intermittent dilatations. In the Collis-Belsey group (17 patients), after an average follow-up of 42 months, reflux symptoms have been eliminated in 11, are mild in three, and moderate or severe in three. Distal esophageal high-pressure zone (HPZ) tone and length have increased from an average of 4.6 mm Hg and 1.6 cm preoperatively to 8.6 mm Hg and 2.3 cm postoperatively. Acid reflux testing with the intraesophageal pH electrode, however, has demonstrated moderate-to-severe reflux in seven patients (41%). In the Collis-Nissen group (20 patients), after an average follow-up of 22 months, reflux symptoms have been eliminated in 17, are mild in two, and severe in one. Average HPZ tone and length have increased from 2.5 mm Hg and 1.2 cm preoperatively to 12 mm Hg and 4.2 cm postoperatively. The acid reflux test has revealed moderate or severe reflux in five patients (25%). Gratifying subjective and objective reflux control can be achieved in scleroderma patients with minimal operative morbidity.

Entities:  

Mesh:

Year:  1981        PMID: 7281001

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  17 in total

1.  Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis.

Authors:  J R Murphy; P McNally; P Peller; S S Shay
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 2.  Role and safety of fundoplication in esophageal disease and dysmotility syndromes.

Authors:  Charles T Bakhos; Roman V Petrov; Henry P Parkman; Zubair Malik; Abbas E Abbas
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

3.  Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis.

Authors:  Jingliang Yan; Andrew T Strong; Gautam Sharma; Scott Gabbard; Prashanti Thota; John Rodriguez; Matthew Kroh
Journal:  Surg Endosc       Date:  2018-02-12       Impact factor: 4.584

4.  Lung Transplantation for Scleroderma-related Lung Disease.

Authors:  Claire B Richardson; Jonathan P Singer
Journal:  Curr Respir Care Rep       Date:  2014-06-22

Review 5.  Advances in the evaluation and management of esophageal disease of systemic sclerosis.

Authors:  Dustin A Carlson; Monique Hinchcliff; John E Pandolfino
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

6.  Esophageal disease in progressive systemic sclerosis.

Authors:  Ellen C Ebert
Journal:  Curr Treat Options Gastroenterol       Date:  2008-02

Review 7.  The surgical management of motility disorders.

Authors:  H Feussner; W Kauer; J R Siewert
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

Review 8.  Treatment of systemic sclerosis.

Authors:  T A Medsger
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

9.  Achalasia of the esophagus. Treatment controversies and the method of choice.

Authors:  P E Donahue; S Samelson; P K Schlesinger; C T Bombeck; L M Nyhus
Journal:  Ann Surg       Date:  1986-05       Impact factor: 12.969

Review 10.  Esophageal manifestation in patients with scleroderma.

Authors:  Theodoros A Voulgaris; Georgios P Karamanolis
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.